MoneyWorks4Me

Zydus Lifesciences - Quaterly Results

03 Feb 2023 Evaluate
A fair growth of 14.02% in the revenue at Rs. 20869.00 millions was reported in the December 2022 quarter as compared to Rs. 18303.00 millions during year-ago period.A good growth in profit of 29.90% reported to Rs. 2559.00  millions over Rs. 1970.00 millions of corresponding previous quarter.Operating Profit saw a handsome growth to 5949.00 millions from 3845.00 millions in the quarter ended December 2022.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202212 202112 % Var 202212 202112 % Var 202203 202103 % Var
Sales 20869.00 18303.00 14.02 64666.00 59626.00 8.45 79819.00 77800.00 2.60
Other Income 1363.00 259.00 426.25 2972.00 1250.00 137.76 1787.00 893.00 100.11
PBIDT 5949.00 3845.00 54.72 19791.00 15855.00 24.82 20968.00 23980.00 -12.56
Interest 885.00 246.00 259.76 1932.00 929.00 107.97 1349.00 709.00 90.27
PBDT 5064.00 3599.00 40.71 17859.00 11733.00 52.21 16426.00 21396.00 -23.23
Depreciation 1216.00 1200.00 1.33 3687.00 3559.00 3.60 4787.00 4511.00 6.12
PBT 3848.00 2399.00 60.40 14172.00 8174.00 73.38 11639.00 16885.00 -31.07
TAX 1289.00 429.00 200.47 3787.00 2064.00 83.48 3060.00 2123.00 44.14
Deferred Tax 427.00 183.00 133.33 465.00 241.00 92.95 458.00 -910.00 -150.33
PAT 2559.00 1970.00 29.90 10385.00 6110.00 69.97 8579.00 14762.00 -41.88
Equity 1012.00 1024.00 -1.17 1024.00 1024.00 0.00 1024.00 1024.00 0.00
PBIDTM(%) 28.51 21.01 35.70 30.60 26.59 15.10 26.27 30.82 -14.77
Peers
Company Name CMP
Sun Pharma. Inds. 1745.00
Dr. Reddys Labs. 1242.00
Cipla 1331.00
Lupin 1953.75
Zydus Lifesciences 1113.00
View more..